跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
萨温珂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Siltuximab for Injection
Approved
生物制品
Siltuximab for Injection
Recordati Netherlands B.V.
🇨🇳 National Medical Products Administration
Approval Date
Nov 30, 2021
Approval ID
8Dqlhty78Yb
Company
Recordati Netherlands B.V.
Type
生物制品
Approval Details
Approval Id
8Dqlhty78Yb
Approval Number
国药准字SJ20210031
Generic Name
注射用司妥昔单抗
Generic Name En
Siltuximab for Injection
Trade Name
萨温珂
Drug Type
生物制品
Dosage Form
注射剂
Strength
100mg/瓶
Reg Date
2021-11-30
Expired Date
2026-11-29
Company Name
Recordati Netherlands B.V.
Production Company Name
Cilag AG
Company Detail Path
/organization/recordati-netherlands-b-v
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 30, 2021
Approval ID
8Dqlhty78Yb
Type
生物制品
Back to NMPA Approvals